Eye on FDA

NOVEMBER 17, 2020

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. While vaccination may actually begin in December, the number of doses will be limited. In addition, the process of vaccination takes time.

Communication 81

Communication Vaccines HIPAA Documentation 81

pharmaphorum

OCTOBER 18, 2021

The development of COVID-19 vaccines required levels of cooperation and pioneering science comparable to the Apollo space programme. Within 12 months of the outbreak, vaccines were being deployed to prevent severe infections, hospitalisation, and death. billion people have been fully vaccinated. COVID-19 vaccine tracker.

Vaccines 143

Vaccines Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 143

pharmaphorum

DECEMBER 16, 2020

Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its efficacy at 94.5%. — Eric Topol (@EricTopol) December 15, 2020. Both vaccines will be provided free of charge to recipients.

Vaccines 98

Vaccines Documentation Diabetes 98

Pharma in Brief

SEPTEMBER 22, 2020

On September 16, 2020, the Minister of Health signed an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 (the Interim Order ) which provides new regulatory pathways to expedite the approval of COVID-19 drugs and vaccines that have not yet been approved for sale in Canada.

Vaccines 98

Vaccines Documentation Labelling 98

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. An analysis performed at the end of 2019 concluded that demand for viral vectors would have surpassed CDMO capacity during 2020.

Vaccines 115

Vaccines Documentation Communication Hospitals 115

Express Pharma

SEPTEMBER 18, 2023

Our virtual twins have been used to swiftly develop COVID-19 vaccines, optimise surgical procedures, and provide patients with a greater understanding of treatment options. Emma Twin is the next act in Dassault Systèmes’ “The Only Progress is Human” initiative, dedicated to healthcare and patient experience.

Documentation 105

Documentation Communication Vaccines 105

Drug Channels

OCTOBER 13, 2020

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Drug Distribution Industry (press release) We’re offering special discounted pricing if you order before October 23, 2020! Copyright © 2006-2020 Pembroke Consulting, Inc.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Hospitals Documentation Vaccines 40

pharmaphorum

APRIL 16, 2021

IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. It is undeniable that 2020 was a particularly challenging year to launch non-COVID innovative prescription medicines.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 95

pharmaphorum

FEBRUARY 19, 2021

Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as this would increase the number of people that can be protected while supplies are limited without compromising its efficacy. . Feature image copyright BioNTech SE 2020, all rights reserved.

Vaccines 72

Vaccines Immunity Immunization Documentation 72

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

pharmaphorum

MAY 16, 2022

In 2020, USAID launched two policy documents to guide how the agency invests in digital infrastructure as part of its development and humanitarian assistance programmes: Digital Strategy and Vision for Action in Digital Health (aka Digital Health Vision).

Documentation 118

Documentation Vaccines 118

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . We published our hypothesis in the Lancet on February 4 in 2020.

Drug Development 93

Drug Development Vaccines Documentation Communication 93

pharmaphorum

OCTOBER 28, 2020

A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceutical companies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

Pharmaceutical Technology

NOVEMBER 15, 2022

Within Pfizer’s Covid-19 pipeline, Pfizer and BioNtech’s vaccine Comirnaty is also being used to fight the pandemic. While bivalent formulations of Comirnaty and Moderna’s Spikevax vaccine have both been authorised for use as boosters in the UK and US, their uptake has remained slow. 7)) and the other one in common between the BA.4

Vaccines 64

Vaccines Documentation 64

European Pharmaceutical Review

JANUARY 16, 2023

He warned, “Implementation of a CCS will require more than writing documents.”. The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” Perhaps we will see a universal flu vaccine in the near future. References.

Vaccines 128

Vaccines Research Laboratories Documentation Compounding 128

pharmaphorum

DECEMBER 19, 2022

So, it was that Poland had to provide the necessary cancer care and, indeed, soon after the war started, it had been decided that refugees would have the same care as Polish patients – despite the difficulties faced by having no Polish documentation. Industry’s learning from the pandemic.

Documentation 97

Documentation Hospitals Communication Vaccines 97

pharmaphorum

SEPTEMBER 14, 2022

With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pandemic, eagerly learning about everything from symptoms to vaccine development. based site management organization.

Vaccines 98

Vaccines Medical Records Documentation Communication 98

Pharma in Brief

OCTOBER 25, 2020

They supersede all previous guidance documents, policy communiqués and written or verbal statements of any kind by the PMPRB regarding the administration of the price review process and investigations, including all previous versions of the PMPRB’s Compendium of Guidelines, Policies and Procedures. Changes to the Guidelines.

Biosimilars 52

Biosimilars Documentation Vaccines 52

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19. The FCA also provided guidance on “inventive concept”.

Documentation 52

Documentation Labelling Vaccines Packaging 52

Putting Patients First Blog

APRIL 30, 2024

Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. The importance of using plain language in health communications is well-documented in literature.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. 13.00 – 17.00.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

Putting Patients First Blog

MARCH 29, 2023

They primarily focus on improving the public health infrastructure, improving the development of treatment and vaccines, and coordinating federal response. These flexibilities and partnerships greatly increased the speed of research and development for COVID-19 testing, treatment, and vaccines. Sincerely, Randall L.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Vaccines Documentation Hospitals 40

Putting Patients First Blog

JULY 22, 2024

This includes wholesalers, payers, and other entities involved in pricing and distribution, all of which significantly influence the availability and cost of medical products, including drugs, biologics, vaccines, and devices. Although these considerations extend beyond the current RFI, the NHC believes they warrant attention. 2024, June 11).

Documentation 52

Documentation Vaccines 52

Pharmaceutical Technology

MAY 11, 2023

The business continuity plan was introduced in 2020 to allow European regulators to prioritise the assessment of Covid-19 therapeutics and vaccines while also handling other responsibilities.

Documentation 52

Documentation Vaccines 52

Putting Patients First Blog

SEPTEMBER 9, 2024

These codes facilitate proper documentation and reimbursement, ensuring that health care providers are fairly compensated for the critical services they offer. Preventive Services The expansion of preventive services, including hepatitis B vaccinations and colorectal cancer screenings, is a positive development for public health.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

RX Note

FEBRUARY 23, 2023

- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Vaccines 52

Vaccines Drug Development Documentation Communication 52

Pharmaceutical Technology

DECEMBER 13, 2022

In 2020, the pharmaceutical supply chain faced one of its biggest global challenges. To develop a vaccine and then get as many people vaccinated as quickly as possible. Advanced monitoring and analysis technology has enabled more than 13 billion COVID-19 vaccinations to be distributed worldwide to date.

Vaccines 52

Vaccines Communication Documentation 52

STAT

MARCH 27, 2025

The worker cuts are in addition to roughly 10,000 employees who opted to leave the department since President Trump took office, through voluntary separation offers, according to the documents. Documents viewed by the Journal say essential health services will not be affected. It will also lose five of its 10 regional offices.

Vaccines 249

Vaccines Documentation 249

pharmaphorum

OCTOBER 7, 2020

The FDA may have been blocked from issuing stricter guidelines for emergency approval of COVID-19 vaccines by the Trump administration, but it has still managed to make its new approach public. — Scott Gottlieb, MD (@ScottGottliebMD) October 6, 2020. Industry is also concerned.

Vaccines 59

Vaccines Documentation Communication 59

The Thyroid Pharmacist

NOVEMBER 8, 2024

1] Additionally, in 2020, a study was published that also ties the eradication of Blasto to improvement in Hashimoto’s, including a reduction in TSH and TPO, as well as a decrease in a particular pro-inflammatory cytokine (IL-17) thought to have a role in Hashimoto’s pathogenesis. [2] Published 2020 Feb 21. Accessed August 6, 2020. [6]

Immunity 72

Immunity Immunization Diabetes Adverse Reactions 72

pharmaphorum

APRIL 22, 2021

Emergent BioSolutions’ difficult month has been made worse by an FDA report into its facility in Baltimore, which has been blamed for the wastage of millions of doses of Johnson & Johnson’s COVID-19 vaccine. . AZ’s vaccine meanwhile has yet to be approved in the US. An FDA decision is expected tomorrow.

Vaccines 52

Vaccines Documentation 52